5/17
08:14 am
ogen
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine [Yahoo! Finance]
High
Report
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine [Yahoo! Finance]
5/17
08:00 am
ogen
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
High
Report
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
5/16
10:50 am
ogen
Oragenics climbs 9% amid Phase 2 study, business updates [Seeking Alpha]
Medium
Report
Oragenics climbs 9% amid Phase 2 study, business updates [Seeking Alpha]
5/16
08:14 am
ogen
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial [Yahoo! Finance]
Medium
Report
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial [Yahoo! Finance]
5/16
08:00 am
ogen
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
Medium
Report
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
5/10
03:30 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/7
08:14 am
ogen
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia [Yahoo! Finance]
High
Report
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia [Yahoo! Finance]
5/7
08:00 am
ogen
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
High
Report
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
5/2
02:05 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/24
02:08 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/19
06:03 pm
ogen
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards [Yahoo! Finance]
High
Report
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards [Yahoo! Finance]
4/19
05:50 pm
ogen
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
High
Report
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
4/8
02:03 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/1
09:09 am
ogen
Oragenics, Inc. Files 10K and Provides Company Update [Yahoo! Finance]
Low
Report
Oragenics, Inc. Files 10K and Provides Company Update [Yahoo! Finance]
4/1
09:05 am
ogen
Oragenics, Inc. Files 10K and Provides Company Update
Low
Report
Oragenics, Inc. Files 10K and Provides Company Update
3/31
02:05 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/27
08:49 am
ogen
Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity [Yahoo! Finance]
Neutral
Report
Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity [Yahoo! Finance]
3/23
02:04 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/18
07:09 am
ogen
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion [Yahoo! Finance]
Medium
Report
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion [Yahoo! Finance]
3/18
07:00 am
ogen
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
Medium
Report
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
3/15
02:15 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/5
07:57 am
ogen
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion [Yahoo! Finance]
Medium
Report
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion [Yahoo! Finance]
3/5
07:45 am
ogen
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
Medium
Report
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
3/1
04:12 pm
ogen
Oragenics Announces Closing of Public Offering [Yahoo! Finance]
Low
Report
Oragenics Announces Closing of Public Offering [Yahoo! Finance]
3/1
04:04 pm
ogen
Oragenics Announces Closing of Public Offering
Low
Report
Oragenics Announces Closing of Public Offering